Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-21 Purchase |
2020-12-23 4:41 pm |
Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Chief Executive Officer 10% Owner |
275,784 | $15.16 | $4,181,208 | 15,514,566 (Indirect) |
View |
| 2020-09-28 Purchase |
2020-09-30 4:01 pm |
Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S Chief Executive Officer 10% Owner |
110,882 | $13.13 | $1,456,408 | 15,238,782 (Indirect) |
View |
| 2020-09-04 Purchase |
2020-09-09 6:55 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner |
278,369 | $3.9402 | $1,096,829 | 9,405,490 (Indirect) |
View |
| 2020-08-28 Purchase |
2020-09-01 08:17 am |
Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S Chief Executive Officer 10% Owner |
1,052,631 | $14.25 | $14,999,992 | 15,127,900 (Indirect) |
View |
| 2020-08-12 Purchase |
2020-08-14 4:49 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner |
431,647 | $3.7185 | $1,605,100 | 9,127,121 (Indirect) |
View |
| 2020-06-02 Purchase |
2020-06-04 6:26 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner |
615,129 | $4.9054 | $3,017,479 | 8,695,474 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-26 Option Award |
2021-03-02 4:03 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
34 | $17.89 | 15,517,183 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:03 pm |
N/A 2031-02-26 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
34 | $0 | 15,517,183 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-18 4:24 pm |
N/A 2031-02-12 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
535 | $0 | 9,409,249 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-18 4:24 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
535 | $5.7035 | 9,409,249 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-17 4:07 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
28 | $21.19 | 15,517,143 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-17 4:07 pm |
N/A 2031-02-12 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
28 | $0 | 15,517,143 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 5:21 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
118 | $5.202 | 9,408,297 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 5:21 pm |
N/A 2031-01-29 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
118 | $0 | 9,408,297 (Direct) |
View |
| 2021-01-15 Option Award(A) |
2021-02-02 5:20 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
136 | $4.5475 | 2,571 (Direct) |
View |
| 2020-12-31 Option Award(A) |
2021-02-02 5:18 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
1,648 | $3.298 | 4,083 (Direct) |
View |
| 2020-12-31 Option Award(A) |
2021-02-02 5:18 pm |
N/A 2030-12-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
1,648 | $0 | 4,083 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 4:10 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
31 | $19.64 | 15,517,118 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 4:10 pm |
N/A 2031-01-29 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
31 | $0 | 15,517,118 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:57 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
136 | $4.5475 | 9,406,720 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:57 pm |
N/A 2031-01-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
136 | $0 | 9,406,720 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:01 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
35 | $16.99 | 15,517,091 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:01 pm |
N/A 2031-01-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
35 | $0 | 15,517,091 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:32 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
171 | $3.298 | 9,406,619 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:32 pm |
N/A 2030-12-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
171 | $0 | 9,406,619 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:06 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
350 | $16.32 | 15,517,371 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:06 pm |
N/A 2030-12-31 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
350 | $0 | 15,517,371 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:01 pm |
N/A 2030-12-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
43 | $0 | 15,240,930 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:01 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
43 | $12.91 | 15,240,930 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-16 4:22 pm |
N/A 2030-12-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
147 | $0 | 9,406,424 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-16 4:22 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
147 | $3.825 | 9,406,424 (Direct) |
View |
| 2020-12-10 Option Award |
2020-12-14 4:24 pm |
N/A 2030-12-10 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
52,191 | $0 | 52,191 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-10 4:06 pm |
N/A 2030-12-08 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
22,639 | $0 | 22,639 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:21 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
134 | $4.225 | 9,406,264 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:21 pm |
N/A 2030-11-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
134 | $0 | 9,406,264 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:02 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
45 | $12.77 | 15,240,889 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:02 pm |
N/A 2030-11-30 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
45 | $0 | 15,240,889 (Direct) |
View |
| 2020-11-13 Option Award |
2020-11-17 4:13 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
141 | $3.978 | 9,406,137 (Direct) |
View |
| 2020-11-13 Option Award |
2020-11-17 4:13 pm |
N/A 2030-11-13 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
141 | $0 | 9,406,137 (Direct) |
View |
| 2020-11-13 Option Award |
2020-11-17 4:06 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
46 | $12.2 | 15,240,845 (Direct) |
View |
| 2020-11-13 Option Award |
2020-11-17 4:06 pm |
N/A 2030-11-13 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
46 | $0 | 15,240,845 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-05 4:59 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
196 | $2.89 | 9,406,051 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-05 4:59 pm |
N/A 2030-10-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
196 | $0 | 9,406,051 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-03 4:06 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
46 | $12.25 | 15,240,799 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-03 4:06 pm |
N/A 2030-10-30 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
46 | $0 | 15,240,799 (Direct) |
View |
| 2020-10-15 Option Award |
2020-10-19 9:14 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
169 | $3.32 | 9,405,828 (Direct) |
View |
| 2020-10-15 Option Award |
2020-10-19 9:14 pm |
N/A 2030-10-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
169 | $0 | 9,405,828 (Direct) |
View |
| 2020-10-15 Option Award |
2020-10-19 4:04 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
42 | $13.35 | 15,240,749 (Direct) |
View |
| 2020-10-15 Option Award |
2020-10-19 4:04 pm |
N/A 2030-10-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
42 | $0 | 15,240,749 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 4:03 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
50 | $11.42 | 15,240,715 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 4:03 pm |
N/A 2030-09-30 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
50 | $0 | 15,240,715 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 4:13 pm |
N/A 2030-09-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
43 | $0 | 15,129,776 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 4:13 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
43 | $13.06 | 15,129,776 (Direct) |
View |
| 2020-08-31 Option Award |
2020-09-02 4:03 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
42 | $13.73 | 15,129,732 (Direct) |
View |
| 2020-08-31 Option Award |
2020-09-02 4:03 pm |
N/A 2030-08-31 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
42 | $0 | 15,129,732 (Direct) |
View |
| 2020-08-14 Option Award |
2020-08-18 4:03 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
18 | $30.71 | 14,077,035 (Direct) |
View |
| 2020-08-14 Option Award |
2020-08-18 4:03 pm |
N/A 2030-08-14 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
18 | $0 | 14,077,035 (Direct) |
View |
| 2020-07-31 Option Award |
2020-08-04 4:03 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
18 | $30.91 | 14,077,017 (Direct) |
View |
| 2020-07-31 Option Award |
2020-08-04 4:03 pm |
N/A 2030-07-31 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
18 | $0 | 14,077,017 (Direct) |
View |
| 2020-07-15 Option Award |
2020-07-17 4:04 pm |
N/A 2030-07-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
17 | $0 | 14,076,998 (Direct) |
View |
| 2020-07-15 Option Award |
2020-07-17 4:04 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
17 | $34.99 | 14,076,998 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:25 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
15 | $35.99 | 14,076,979 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:25 pm |
N/A 2030-06-30 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
15 | $0 | 14,076,979 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 4:27 pm |
N/A 2030-06-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
17 | $0 | 14,076,966 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 4:27 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
17 | $34.21 | 14,076,966 (Direct) |
View |
| 2020-06-01 Option Award |
2020-06-03 4:05 pm |
N/A 2030-06-01 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:04 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
40 | $27.77 | 14,076,972 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:04 pm |
N/A 2030-05-29 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
40 | $0 | 14,076,972 (Direct) |
View |